14:51:05 EST Fri 13 Nov 2026
Enter Symbol
or Name
USA
CA



Merck CDR (CAD Hedged)
Symbol MRK
Shares Issued 1,250,000
Close 2026-11-12 C$ 32.62
Market Cap C$ 40,775,000
Recent Sedar+ Documents

Globe says Merck vaccine may help with new Congo Ebola

2026-11-13 07:57 ET - In the News

The Globe and Mail reports in its Friday, Nov. 13, edition that rebel attacks are killing healthcare workers and destroying clinics in Congo's Ebola zone, jeopardizing efforts to combat the fastest-spreading Ebola outbreak in history. The Globe's Geoffrey York writes that violence is compounding existing challenges, including shortages of basic supplies like phones, fuel and water. In just six months, the epidemic has infected over 11,100 people and killed more than 5,430, making it the second-largest outbreak in history and expanding faster than the deadliest Ebola epidemic, which claimed over 11,300 lives in West Africa from 2014 to 2016. Despite the negative trends, there are early signs that a Canadian-developed vaccine designed for a different Ebola virus could be effective against the Bundibugyo Ebola virus that is rampant in eastern Congo, Doctors Without Borders said this week. The vaccine is now manufactured by Merck, WHO director-general Tedros Adhanom Ghebreyesus said the rising insecurity in eastern Congo is now one of the greatest obstacles to the Ebola response. WHO officials say the Ebola outbreak "remains out of control" and basic resources are still lacking in the often dysfunctional response.

© 2026 Canjex Publishing Ltd. All rights reserved.